Basepoint Wealth’s Zimmer Biomet ZBH Stock Holding History

Basepoint Wealth’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$34.5K	Sell	382 -42	-10%	-$3.85K	0.02%	260
2025 Q4	$38.2K	Buy	+424	New	+$40.2K	0.02%	235
2024 Q1	–	Sell	-1,667	Closed	-$203K	–	121
2023 Q4	$203K	Sell	1,667 -567	-25%	-$63.3K	0.16%	98
2023 Q3	$251K	Sell	2,234 -13	-0.6%	-$1.65K	0.2%	88
2023 Q2	$327K	Sell	2,247 -245	-10%	-$33.3K	0.27%	78
2023 Q1	$322K	Sell	2,492 -28	-1%	-$3.52K	0.27%	74
2022 Q4	$321K	Buy	2,520 +4	+0.2%	+$464	0.28%	70
2022 Q3	$263K	Sell	2,516 -268	-10%	-$29.4K	0.28%	69
2022 Q2	$292K	Sell	2,784 -45	-2%	-$5.34K	0.31%	69
2022 Q1	$362K	Sell	2,829 -222	-7%	-$26.8K	0.33%	46
2021 Q4	$376K	Buy	+3,051	New	+$399K	0.37%	47

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Basepoint Wealth's ZBH Position: Q1 2026 in Review

Basepoint Wealth reduced its Zimmer Biomet (ZBH) stake by 9.9% in Q1 2026, selling an estimated $3.85K and leaving 382 shares worth $34.5K. The position accounts for 0.02% of the portfolio, ranked #260.

Basepoint Wealth first reported a position in ZBH in Q4 2021 and has held it in 11 quarters since. The position peaked at $376K in Q4 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Basepoint Wealth held 382 shares of Zimmer Biomet worth $34.5K as of Q1 2026.
Basepoint Wealth sold 42 Zimmer Biomet shares in Q1 2026, an estimated $3.85K.
Zimmer Biomet made up 0.02% of Basepoint Wealth's portfolio in Q1 2026, its #260 holding.
Basepoint Wealth first reported a position in Zimmer Biomet in Q4 2021 and has held it in 11 quarters since.
Basepoint Wealth's Zimmer Biomet position peaked at $376K in Q4 2021.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Basepoint Wealth's 13F filing for Q1 2026, filed 7 May 2026.